CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-α, IFN-γ, and sIL-2R levels in aging
- 1 January 1999
- journal article
- Published by Elsevier in Experimental Gerontology
- Vol. 34 (1) , 79-93
- https://doi.org/10.1016/s0531-5565(98)00058-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Anthropometric measurements from a cross-sectional survey of community dwelling subjects aged over 90 years of ageEuropean Journal of Clinical Nutrition, 1997
- Interleukin 2 and its receptors: recent advances and new immunological functionsImmunology Today, 1996
- CD4 lymphopenia in very elderly peopleThe Lancet, 1996
- Biological Implications of HLA‐DR Expression in TumoursScandinavian Journal of Immunology, 1995
- The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cellsImmunology Today, 1994
- Age-Related Changes in Human Blood Lymphocyte SubpopulationsClinical Immunology and Immunopathology, 1994
- Natural history of HLA expression during tumour developmentImmunology Today, 1993
- Age-Related Changes in the Expression of IL-2 and High-Affinity IL-2-Binding SitesInternational Archives of Allergy and Immunology, 1993
- Tumor necrosis factor‐α production induced in T lymphocytes through the AIM/CD69 activation pathwayEuropean Journal of Immunology, 1992
- Age-related changes in human lymphocyte subsets: Progressive reduction of the CD4 CD45R (suppressor inducer) populationClinical Immunology and Immunopathology, 1988